Sunday November 22 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Immune Network Ltd.

We are not a traditional biotech company. Industries such as high tech and real estate have their merchant developers - organizations who recognize the potential of an idea or property. They analyze market potential, existing infrastructure and current problems, acquire the project and take it forward to the point of re-sale to another developer or final market. That's what we're doing in the biopharmaceutical industry. When projects stall or go dormant, their intrinsic technology value may remain high, but their financial valuations drop. Once we acquire a project, we rebuild its value by rapidly 'solving' the problem or problems and by getting the project back on track. Once we accomplish this, we either license, form an alliance, or spin off the technology in order to realize a return on investment


Contact Details:
1707 West 4th Avenue
Vancouver
British Columbia
V6J 1M2
Canada
Tel:(604) 742-0065
Fax:
Email:info@immunenetwork.com
WWW:

www.immunenetwork.com/




Loading...

Recent Publications by Immune Network Ltd.:

The anti-idiotypic antibody 1F7 selectively inhibits cytotoxic T cells activated in HIV-1 infection.
Circulating CD8+ T lymphocyte numbers rise substantially following...
25th March, 2000
Immune Network Immunol Cell Biol. 2000 Feb;78(1):20-7.
DOI Direct Link

BioNews Results for Immune Network Ltd.:

Hepatitis B Immune Globulin Therapy May Improve Graft and Patient Survival After Liver Transplantation: Presen
Doctors Guide:  Nov 2 2009 11:17PM Matching: immune network
Psoriasis, more than superficial
Express Pharma:  Oct 26 2009 2:12PM Matching: immune network
Immune-related proteins are potential drug targets for gastric inflammation and cancer
News-Medical.Net:  Oct 19 2009 10:11AM Matching: immune network
Inovio Biomedical Announces Initiation of HIV Clinical Trial for DNA Vaccine Delivered Using Electroporation
Pharma Live:  Oct 16 2009 6:52AM Matching: immune network
The 20-Year Future for Seattle Biotech, As Told By Industry Visionaries, Coming Monday
Xconomy:  Oct 15 2009 5:46AM Matching: immune network
Promote your company here: BioNewsCast - Press Release Distribution

View more Immune Network Ltd. news.

Immune Network Ltd. Patents:

US Patent No.Title
6221580 Anti-idiotypic and its uses in diagnosis and therapy in HIV-related disease
5230887 Immune system stabilizers for prevention and therapy of disorders associated with immune system disfunction

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 352 times since April 2007, the link to the organisation's website has been followed 59 times

Recent Search Terms used to find this page: immune network ltd news 2009 | immune network ltd. swine flue | .

Search for more companies in Vancouver

Search for more companies in British Columbia



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Immune Network Ltd.

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.